Clinical Trial Update: Low-Dose Dobutamine Tc-99m-Mibi Gated SPECT to Predict Left Ventricular Remodelling in Patients Reperfused in the Acute Phase of MI [NA]

View source ↗

Summary

This completed clinical trial evaluated whether low-dose dobutamine with Tc-99m MIBI gated SPECT can predict left ventricular remodeling after reperfused acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease
• Myocardial Infarction

Drugs mentioned

• Dobutamine (dobutamine)
• Technetium-99m sestamibi (Technetium-99m sestamibi)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Ischemic Heart Disease, Myocardial Infarction | NA | Status: COMPLETED